Cerebrooculofacioskeletal Syndrome 4; Cofs4

Description

Cerebrooculofacioskeletal syndrome-4 is a severe autosomal recessive disorder characterized by growth retardation, dysmorphic facial features, arthrogryposis, and neurologic abnormalities. Cellular studies show a defect in both transcription-coupled and global genome nucleotide excision repair (TC-NER and GG-NER) (summary by Jaspers et al., 2007 and Kashiyama et al., 2013).For a discussion of genetic heterogeneity of cerebrooculofacioskeletal syndrome, see {214150}.

Clinical Features

Top most frequent phenotypes and symptoms related to Cerebrooculofacioskeletal Syndrome 4; Cofs4

  • Global developmental delay
  • Short stature
  • Microcephaly
  • Growth delay
  • Nystagmus
  • Micrognathia
  • Abnormal facial shape
  • Flexion contracture
  • Hyperreflexia
  • Intrauterine growth retardation

And another 38 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
No data available about the known clinical features onset.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Cerebrooculofacioskeletal Syndrome 4; Cofs4 Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Cerebrooculofacioskeletal syndrome 4 (sequence analysis of ERCC1 gene).

By CGC Genetics (Portugal).

ERCC1
Specificity
100 %
Genes
100 %
Xeroderma Pigmentosum Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics (United States).

XPA, XPC, DDB2, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, POLH
Specificity
12 %
Genes
100 %
Xeroderma pigmentosum Comprehensive panel.

By Connective Tissue Gene Tests (United States).

XPA, XPC, DDB2, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, POLH
Specificity
12 %
Genes
100 %
Xeroderma pigmentosum NGS panel.

By Connective Tissue Gene Tests (United States).

XPA, XPC, DDB2, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, POLH
Specificity
12 %
Genes
100 %
Xeroderma pigmentosum Deletion / Duplication panel.

By Connective Tissue Gene Tests (United States).

XPA, XPC, DDB2, ERCC1, ERCC2, ERCC3, ERCC4, ERCC5, POLH
Specificity
12 %
Genes
100 %
Cerebrooculofacioskeletal syndrome Comprehensive panel.

By Connective Tissue Gene Tests (United States).

ERCC1, ERCC2, ERCC5, ERCC6
Specificity
25 %
Genes
100 %
Cerebrooculofacioskeletal syndrome NGS panel.

By Connective Tissue Gene Tests (United States).

ERCC1, ERCC2, ERCC5, ERCC6
Specificity
25 %
Genes
100 %
Cerebrooculofacioskeletal syndrome Deletion / Duplication panel.

By Connective Tissue Gene Tests (United States).

ERCC1, ERCC2, ERCC5, ERCC6
Specificity
25 %
Genes
100 %

You can get up to 21 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM MESH Genetic Syndrome Finder

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like RITSCHER-SCHINZEL SYNDROME 1; RTSC1 NEMALINE MYOPATHY 1; NEM1 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D DUANE RETRACTION SYNDROME 2; DURS2 ATAXIA-PANCYTOPENIA SYNDROME; ATXPC EPIDERMOLYSIS BULLOSA SIMPLEX WITH MIGRATORY CIRCINATE ERYTHEMA PORPHYRIA CUTANEA TARDA